Decisions taken by Orion Corporation's Annual General Meeting and Board of Directors' organising meeting on 24 March 20263/24/2026 Stock exchange release
ORION CORPORATION STOCK EXCHANGE RELEASE – DECISIONS OF GENERAL MEETING 24 MARCH 2026 at 16.30 EET D...
Publisher
Finland
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
ORION CORPORATION STOCK EXCHANGE RELEASE – DECISIONS OF GENERAL MEETING 24 MARCH 2026 at 16.30 EET D...
Source route
Continue on orionpharma.com
Leave the platform to read the original full article on the publisher site.
Source: Orion Corporation
Scope: Industry
Related coverage
More related coverage
Global Alliances: Structuring Successful Cross-Border Life Sciences Partnerships
Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis
Johnson & Johnson presents new data showing high rates of complete skin clearance achieved at Week 2...